Myc is a transcription factor that plays a key role in many cellular functions. When deregulated, it becomes a potent oncogene and a hallmark of many human cancers. Although its activity has been proven to strongly depend on many cofactors, we are still far from a comprehensive understanding of Myc’s mechanisms of action in transcriptional control. Moreover, since Myc itself is not easily druggable, targeting its cofactors or downstream effectors may constitute a more promising therapeutic strategy in Myc-driven tumors. Here, we have used the Chromatin Proteomics (ChroP) technology to identify new Myc interactors. Among the list of identified candidates, we have chosen to focus our attention on two lymphocyte specific transcription factors, Ikaros and Aiolos. We validated the interaction of Myc with these factors and started to study its functional meaning. Our working hypothesis is that Myc and Ikaros/Aiolos antagonize each other on chromatin at selected target loci. We were able to identify a subset of genes regulated in opposite manners by Ikaros and Myc, involved mainly in cell cycle regulation, metabolism of lipids and metabolic stress response; the next step will be to study more in depth the mechanisms behind their regulation and their functional significance.

PROTEOMIC IDENTIFICATION OF THE TRANSCRIPTION FACTORS IKAROS AND AIOLOS AS NEW MYC INTERACTORS ON CHROMATIN / C.v. Locarno ; added supervisor: A. Sabo'; supervisor: B. Amati. - : . DIPARTIMENTO DI ONCOLOGIA ED EMATO-ONCOLOGIA, Università degli Studi di Milano, 2018 Mar 26. ((29. ciclo, Anno Accademico 2017. [10.13130/locarno-chiara-veronica_phd2018-03-26].

PROTEOMIC IDENTIFICATION OF THE TRANSCRIPTION FACTORS IKAROS AND AIOLOS AS NEW MYC INTERACTORS ON CHROMATIN

C.V. Locarno
2018-03-26

Abstract

Myc is a transcription factor that plays a key role in many cellular functions. When deregulated, it becomes a potent oncogene and a hallmark of many human cancers. Although its activity has been proven to strongly depend on many cofactors, we are still far from a comprehensive understanding of Myc’s mechanisms of action in transcriptional control. Moreover, since Myc itself is not easily druggable, targeting its cofactors or downstream effectors may constitute a more promising therapeutic strategy in Myc-driven tumors. Here, we have used the Chromatin Proteomics (ChroP) technology to identify new Myc interactors. Among the list of identified candidates, we have chosen to focus our attention on two lymphocyte specific transcription factors, Ikaros and Aiolos. We validated the interaction of Myc with these factors and started to study its functional meaning. Our working hypothesis is that Myc and Ikaros/Aiolos antagonize each other on chromatin at selected target loci. We were able to identify a subset of genes regulated in opposite manners by Ikaros and Myc, involved mainly in cell cycle regulation, metabolism of lipids and metabolic stress response; the next step will be to study more in depth the mechanisms behind their regulation and their functional significance.
AMATI, BRUNO
ALCALAY, MYRIAM
Myc; proteomics; interactors; cofactors; ChroP; mass spectrometry; Ikaros; Aiolos
Settore BIO/11 - Biologia Molecolare
PROTEOMIC IDENTIFICATION OF THE TRANSCRIPTION FACTORS IKAROS AND AIOLOS AS NEW MYC INTERACTORS ON CHROMATIN / C.v. Locarno ; added supervisor: A. Sabo'; supervisor: B. Amati. - : . DIPARTIMENTO DI ONCOLOGIA ED EMATO-ONCOLOGIA, Università degli Studi di Milano, 2018 Mar 26. ((29. ciclo, Anno Accademico 2017. [10.13130/locarno-chiara-veronica_phd2018-03-26].
Doctoral Thesis
File in questo prodotto:
File Dimensione Formato  
phd_unimi_R10755.pdf

embargo fino al 01/09/2019

Descrizione: Tesi Dottorato
Tipologia: Tesi di dottorato completa
Dimensione 11.13 MB
Formato Adobe PDF
11.13 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/558480
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact